Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry.
Sytske Anne BergstraJaime C BrancoDavid Vega MoralesKaren Salomon-EscotoNimmisha GovindCornelia F AllaartRobert B M LandewéPublished in: Annals of the rheumatic diseases (2018)
Disease activity in patients with rheumatoid arthritis as well as bDMARD-usage varies across countries worldwide. The (negative) relationship between countries' bDMARD-usage and level of disease activity is complex and under the influence of many factors, including-but not limited to-countries' SES, affordability of bDMARDs and valid prescription and reimbursement rules for bDMARDs.